Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
MorphoSys AG
About MOR
MorphoSys AG is a global commercial-stage biopharmaceutical company based in Germany. The Company discovers, develops, and delivers cancer medicines to patients. It markets its proprietary medicine Monjuvi (tafasitamab-cxix) in the United States, a cancer immunotherapy treatment, used to treat patients in combination with lenalidomide with second and later lines of diffuse large B-cell lymphoma (DLBCL) who are not eligible for autologous stem cell transplant. Tafasitamab is also being evaluated in a global clinical trial as a first line therapy for DLBCL. Two additional product candidates are in late and mid-stage clinical development in oncology indications: pelabresib, a small-molecule BET inhibitor, is studied as a treatment for myelofibrosis, a type of bone marrow cancer for which treatment options are limited; and CPI-0209, a second generation EZH2 inhibitor, is studied for treating hematological and solid tumors.
Find out what a historical investment in MorphoSys AG would be worth today using our MOR stock calculator.
Market Capitalisation
-
Price-earnings ratio
-
Dividend yield
-
Volume
-
High today
-
Low today
-
Open price
-
52-week high
-
52-week low
-
Ready to start your investing journey with Stake?
Open an accountHow do I buy MOR shares in Australia?
Buying MOR shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in MorphoSys AG in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in MOR
What is the ticker symbol of MorphoSys AG?
The ticker symbol for MorphoSys AG is MOR.
How much is one share of MOR?
One share of MOR is valued at $18.96 as of 20 May 2026.
What is the market capitalisation of MorphoSys AG MOR?
As of 20 May 2026 MorphoSys AG has a market cap of -.
What is the 52-week high for MorphoSys AG stock?
The MorphoSys AG 52-week high stock price is $NaN.
What is the 52-week low for MorphoSys AG stock?
The MorphoSys AG 52-week low stock price is $NaN.
Can I buy MOR shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy MOR shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in MOR on Stake
- Buy MOR from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of MOR from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
MOR related stocks